Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence https://t.co/NeawsNgBmV https://t.co/DMqtdecZtK
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2021 – Nov 2022Where it's discussed
-
X / Twitter9 posts
-
News2 articles
-
Blogs2 articles
-
YouTube1 videos
AI synopsis
What people are saying
The discussions highlight excitement about the potential of activating NRF2 as a innovative strategy, with phrases like 'novel therapeutic approach' and 'counteract cellular senescence.' The tone reflects a recognition of the study's importance, and the emphasis on mechanistic insights indicates a keen interest in understanding the broader implications for aging and disease prevention.
Most posts strongly agree on the potential of NRF2 activation as a promising therapeutic approach for combating cellular senescence.
Discussions demonstrate high interest, with posts emphasizing the significance of the molecular findings and their potential implications.
While some posts briefly mention the study, others delve into mechanisms and future applications, showing a moderate level of engagement.
The majority believe this research could lead to impactful therapies addressing aging and related diseases.
Abstract in brief
- The study identifies SR9009 as a small molecule that suppresses the senescence-associated secretory phenotype (SASP), which is linked to inflammation and chronic disease.
- SR9009 works by activating the NRF2 pathway, reducing reactive oxygen species (ROS) levels and inhibiting DNA damage response, thereby preventing cellular senescence in both cell models and mouse experiments.
- These findings suggest that activating NRF2 with compounds like SR9009 could be a new therapeutic approach to control or prevent diseases related to cellular aging and senescence.
Top posts
Most liked on X and BlueskyRT @hernangraffe: https://t.co/TpOaNXiks2
RT @hernangraffe: https://t.co/TpOaNXiks2
https://t.co/TpOaNXiks2
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence https://t.co/d8ZeovPybt To gain mechanistic insights into ageing and longevity: https://t.co/ev3fKAQQ7D https://t.co/Sw8Uba3Nwd
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence.: https://t.co/zuE2IV1z9h
All mentions
Small molecule SR9009 activates NRF2 to prevent cellular aging and inflammation
Please join the interactive discussion at the Journal Club by Dongfa Lin ivLAB. This study identifies SR9009 as a compound that activates NRF2, suppresses harmful senescence responses, and may provide new therapeutic…
Activation of NRF2 may be a novel therapeutic strategy for preventing cellular senescence. https://t.co/ShEsEccZcL
RT @hernangraffe: https://t.co/TpOaNXiks2
RT @hernangraffe: https://t.co/TpOaNXiks2
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular #senescence https://t.co/HbHxRDfB59 https://t.co/CtyaLOTWcv
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence https://t.co/NeawsNgBmV https://t.co/DMqtdecZtK
https://t.co/TpOaNXiks2
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence.: https://t.co/zuE2IV1z9h
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence https://t.co/d8ZeovPybt To gain mechanistic insights into ageing and longevity: https://t.co/ev3fKAQQ7D https://t.co/Sw8Uba3Nwd